Can your immune system predict lung infection worsening?

NCT ID NCT07363798

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how the body's immune response and nutrition are linked to the progression of nontuberculous mycobacterial pulmonary disease (NTM-PD), a chronic lung infection. Researchers will analyze immune cells from the lungs and blood of 50 adults with confirmed or suspected NTM-PD. They will also assess nutritional status and body composition. The goal is to find better ways to predict which patients will need treatment as their disease worsens.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors identify which patients with NTM lung disease are at higher risk of worsening, allowing for earlier and more personalized monitoring.
What could go wrong
This is an observational study, not a treatment trial. It will not test any new drug or therapy. The results may not lead to immediate changes in patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • SMG-SNU Boramae Medical Center

    Seoul, Dongjak-gu, 07061, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.